迈得医疗（688310）披露2025年年度业绩预告，1月26日股价下跌1.57%

Core Viewpoint - The company, Maide Medical, has released its 2025 annual performance forecast, indicating significant revenue growth and a return to profitability, primarily driven by increased sales in smart medical equipment [1]. Group 1: Financial Performance - As of January 26, 2026, Maide Medical's stock closed at 16.26 yuan, down 1.57% from the previous trading day, with a total market capitalization of 2.703 billion yuan [1]. - The company expects to achieve approximately 447.50 million yuan in revenue for 2025, representing a year-on-year growth of 62.81% [1]. - The net profit attributable to the parent company is projected to be around 66.52 million yuan, marking a return to profitability [1]. - The net profit after deducting non-recurring gains and losses is estimated to be about 54.64 million yuan [1]. Group 2: Revenue Drivers - The significant growth in revenue is primarily attributed to a substantial increase in sales of smart medical equipment, particularly in the drug and device combination sector [1].